MN 553 Week 5 Quiz: Pharmacology

Document Content and Description Below

MN 553 Week 5 Quiz: Pharmacology-. Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for: (Points : 1) Excessive sedation Tachycardia and angina Weight gai... n Cold intolerance Question 2.2. Potentially fatal granulocytopenia has been associated with treatment of hyperthyroidism with propylthiouracil. Patients should be taught to report: (Points : 1) Tinnitus and decreased salivation Fever and sore throat Hypocalcemia and osteoporosis Laryngeal edema and difficulty swallowing Question 3.3. Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it: (Points : 1) Substitutes for insulin usually secreted by the pancreas Decreases glycogenolysis by the liver Increases the release of insulin from beta cells Decreases peripheral glucose utilization Question 4.4. Hypoglycemia can result from the action of either insulin or an oral hypoglycemic. Signs and symptoms of hypoglycemia include: (Points : 1) “Fruity” breath odor and rapid respiration Diarrhea, abdominal pain, weight loss, and hypertension Dizziness, confusion, diaphoresis, and tachycardia Easy bruising, palpitations, cardiac dysrhythmias, and coma Question 5.5. Sulfonylureas may be added to a treatment regimen for type 2 diabetics when lifestyle modifications and metformin are insufficient to achieve target glucose levels. Sulfonylureas have been moved to Step 2 therapy because they: (Points : 1) Increase endogenous insulin secretion Have a significant risk for hypoglycemia Address the insulin resistance found in type 2 diabetics Improve insulin binding to receptors Question 6.6. Treatment with insulin for type 1 diabetics: (Points : 1) Starts with a total daily dose of 0.2 to 0.4 units per kg of body weight Divides the total doses into three injections based on meal size Uses a total daily dose of insulin glargine given once daily with no other insulin required Is based on the level of blood glucose Question 7.7. The American Heart Association states that people with diabetes have a 2- to 4-fold increase in the risk of dying from cardiovascular disease. Treatments and targets that do not appear to decrease risk for micro- and macro-vascular complications include: (Points : 1) Glycemic targets between 7% and 7.5% Use of insulin in type 2 diabetics Control of hypertension and hyperlipidemia Stopping smoking Question 8.8. Drugs used to treat diabetic peripheral neuropathy include: (Points : 1) Metoclopramide [Show More]

Last updated: 1 year ago

Preview 1 out of 6 pages